Status | Study |
Recruiting |
Study Name: Safety, Tolerability and Pharmacokinetic Study of MRG-106 in Patients With Cutaneous T Cell Lymphoma (CTCL), MF Subtype Condition: Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides Date: 2015-10-15 Interventions: Drug: MRG-106 Decreasing intra |
Not yet recruiting |
Study Name: Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma Condition: Mycosis Fungoides Date: 2014-11-19 Interventions: Drug: 3.75% Imiquimod Cream CT |
Recruiting |
Study Name: Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma Condition: Mycosis Fungoides Date: 2014-11-07 Interventions: Drug: Valchlor Valchlor gel 0.016% Other Name: Mechl |
Active, not recruiting |
Study Name: Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome Condition: Recurrent Mycosis Fungoides and Sezary Syndrome Stage IB Date: 2014-09-16 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides Condition: CD30 Positive Cutaneous T Cell Lymphoma CD30 Positive Transformed Myco Date: 2012-07-11 Interventions: Genetic: Genetically modified T cells # 1138 |
Active, not recruiting |
Study Name: PUVA Maintenance Therapy in Mycosis Fungoides Condition: Patch/Plaque Stage Mycosis Fungoides Date: 2012-05-09 Interventions: Drug: 8-methoxypsoralen 8-methoxypsoralen 10mg per 20 kg body weight 1 hour before UVA exposure |
Completed |
Study Name: Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides Condition: Lymphoma Date: 2010-02-19 Interventions: Radiation: TSEBT Total skin electron beam therapy (TSEBT) to a total dose of 12 Gray (TSEBT 12 Gy), low- |
Terminated |
Study Name: Phase 2 Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides Condition: Mycosis Fungoides Lymphomas: Non-Hodgkin Date: 2009-09-24 Interventions: Radiation: Total Skin Electron Beam Therapy (TSEBT) The purpose of the study is to examine the efficacy |
Terminated |
Study Name: PUVA Versus PUVA + IFN Alpha 2a in Mycosis Fungoides Condition: Cutaneous T-Cell Lymphoma (Mycosis Fungoides) Date: 2008-02-28 Interventions: Drug: PUVA (8MOP + UVA) + IFN |
Completed |
Study Name: An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides Condition: Mycosis Fungoides Date: 2007-09-24 Interventions: Drug: 0.04% Mechlorethamine gel Mechlorethamine 0.04% PG applied to affected skin areas (lesions) once d |